MEDINDIA
English
हिन्दी
Español
français
中文
Email
Abacavir
Ribavirin may increase the hepatotoxic activities of Abacavir.
Azathioprine
The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Ribavirin.
Didanosine
The risk or severity of adverse effects can be increased when Ribavirin is combined with Didanosine.
Emtricitabine
Ribavirin may increase the hepatotoxic activities of Emtricitabine.
Entecavir
Ribavirin may increase the hepatotoxic activities of Entecavir.
Entecavir Anhydrous
Ribavirin may increase the hepatotoxic activities of Entecavir.
Interferon Alfa-2a
The risk or severity of adverse effects can be increased when Interferon Alfa-2a, Recombinant is combined with Ribavirin.
Interferon Alfa-2b
The risk or severity of adverse effects can be increased when Interferon Alfa-2b, Recombinant is combined with Ribavirin.
Interferon Alfa-n3
The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ribavirin.
Interferon Alfacon-1
The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Ribavirin.
Lamivudine
Ribavirin may increase the hepatotoxic activities of Lamivudine.
Peginterferon Alfa-2a
The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ribavirin.
Peginterferon Alfa-2b
The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ribavirin.
Stavudine
Ribavirin may increase the hepatotoxic activities of Stavudine.
Zalcitabine
Ribavirin may increase the hepatotoxic activities of Zalcitabine.
Zidovudine
The risk or severity of adverse effects can be increased when Zidovudine is combined with Ribavirin.
